πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

Chinese University of Pipeline

All ClinicalTrials.gov programs at Chinese University of β€” phase, modality, and trial IDs.

Programs
42

Quick answer

Chinese University of has 42 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Acu-TENS

    Chinese University of Hong Kong

    Pain

    phase 3 other completed

    1 trial

  2. Endoscopic submucosal dissection

    Chinese University of Hong Kong

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  3. Epinephrine

    Chinese University of Hong Kong

    Gastric Neoplasm

    phase 3 small molecule completed

    1 trial

  4. Tissue Plasminogen Activator

    Chinese University of Hong Kong

    Pleural Infection

    phase 3 small molecule active

    1 trial

  5. Unified protocol for adolescents (UP-A)

    Chinese University of Hong Kong

    Depressive Disorder

    phase 3 other completed

    1 trial

  6. paricalcitol

    Chinese University of Hong Kong

    IgA Nephropathy

    phase 3 small molecule terminated

    1 trial

  7. Almonertinib 110 MG

    Chinese University of Hong Kong

    Rare Tumor

    phase 2 small molecule active

    1 trial

  8. Apatinib

    Chinese University of Hong Kong

    Head and Neck Neoplasms

    phase 2 small molecule active

    1 trial

  9. Apatinib Mesylate +SHR-1210

    Chinese University of Hong Kong

    Hepatocellular Carcinoma

    phase 2 other active

    1 trial

  10. Chinese Herb

    Chinese University of Hong Kong

    COVID-19

    phase 2 small molecule active

    1 trial

  11. Chinese Medicine Oral Rinse Formula-I (CMORF-I)

    Chinese University of Hong Kong

    Head and Neck Neoplasms

    phase 2 small molecule active

    1 trial

  12. Cisplatin and Doxorubicin

    Chinese University of Hong Kong

    Gastric Cancer Peritoneal Metastases

    phase 2 small molecule active

    1 trial

  13. Colon originated: Neostigmin, Colonoscopy decompression, Surgery

    Chinese University of Hong Kong

    Acute Lower Gastrointestinal Dysfunction

    phase 2 other active

    1 trial

  14. Fezolinetant

    Chinese University of Hong Kong

    Vasomotor Symptoms

    phase 2 small molecule active

    1 trial

  15. Fludrocortisone 100 mcg daily

    Chinese University of Hong Kong

    Sepsis

    phase 2 small molecule active

    1 trial

  16. Iparomlimab/Tuvonralimab

    Chinese University of Hong Kong

    LOCALLY ADVANCED CERVICAL CANCERS

    phase 2 small molecule active

    1 trial

  17. Nimotuzumab

    Chinese University of Hong Kong

    Esophageal Cancer

    phase 2 small molecule completed

    1 trial

  18. Per-Oral Endoscopic Myotomy

    Chinese University of Hong Kong

    Primary Esophageal Motility Disorders Including Achalasia and Hypertensive LES

    phase 2 other active

    1 trial

  19. Programmed Cell Death Protein 1 Inhibitor

    Chinese University of Hong Kong

    Locally Advanced Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  20. RC48-ADC

    Chinese University of Hong Kong

    Muscle Invasive Bladder Carcinoma

    phase 2 small molecule active

    1 trial

  21. SIRT Yttrium-90

    Chinese University of Hong Kong

    Cholangio Carcinoma

    phase 2 small molecule completed

    1 trial

  22. rituximab

    Chinese University of Hong Kong

    Systemic Lupus Erythematosus

    phase 2 small molecule completed

    1 trial

  23. Amlodipine, Telmisartan, Amiloride Compound , Simvastatin

    Chinese University of Hong Kong

    Essential Hypertension

    approved small molecule active

    1 trial

  24. Baricitinib 4 MG

    Chinese University of Hong Kong

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  25. Finerenone

    Chinese University of Hong Kong

    Patients With Type 2 Diabetes

    approved small molecule active

    1 trial

  26. Pegyinterferon-alfa-2a

    Chinese University of Hong Kong

    Chronic Hepaititis B

    approved small molecule completed

    1 trial

  27. Sodium valproate

    Chinese University of Hong Kong

    Epilepsy

    approved small molecule active

    1 trial

  28. film dressing by adhesive

    Chinese University of Hong Kong

    Chronic Peritoneal Dialysis

    approved other terminated

    1 trial

  29. inactivated EV71 vaccine (KMB-17 cells)

    Chinese University of Hong Kong

    Hand, Foot and Mouth Disease (HFMD)

    approved mab completed

    1 trial

  30. lactate group:lactate acide clearance directed group; ScvO2 group:ScvO2 directed group;control group

    Chinese University of Hong Kong

    Shock, Septic

    approved other completed

    1 trial

  31. tacrolimus

    Chinese University of Hong Kong

    Lupus Nephritis

    approved small molecule completed

    1 trial

  32. Clarithromycin

    Chinese University of Hong Kong

    Bronchiectasis Adult

    small molecule active

    1 trial

  33. Computer Aided Diagnosis

    Chinese University of Hong Kong

    Upper Gastrointestinal Disorder

    other completed

    1 trial

  34. Du-Huo-Ji-Sheng-Tang (DHJST)

    Chinese University of Hong Kong

    Knee Osteoarthritis

    small molecule active

    1 trial

  35. EUS-guided portal vein and hepatic vein aspiration

    Chinese University of Hong Kong

    Circulating Tumor Cell

    other active

    1 trial

  36. Intensive BP control

    Chinese University of Hong Kong

    Primary Hypertension

    small molecule active

    1 trial

  37. Mesalazine

    Chinese University of Hong Kong

    Colitis, Ulcerative

    small molecule completed

    1 trial

  38. Methotrexate

    Chinese University of Hong Kong

    Rheumatoid Arthritis

    small molecule completed

    1 trial

  39. Physiotherapy

    Chinese University of Hong Kong

    Knee Arthropathy

    other active

    1 trial

  40. Telbivudine

    Chinese University of Hong Kong

    Chronic Hepatitis B

    small molecule terminated

    1 trial

  41. Western therapy

    Chinese University of Hong Kong

    Hand, Foot and Mouth Disease

    small molecule completed

    1 trial

  42. Ξ²-hydroxy Ξ²-methylbutyrate (HMB) supplement

    Chinese University of Hong Kong

    Sarcopenia

    other active

    1 trial

Frequently asked questions

How many pipeline programs does Chinese University of have?

42 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.